Active

Goods

Medicines

T-947/MPPHSCL/Pharma/RC/2026, Date-21-08-2026

Madhya Pradesh Public Health Services Corporation Ltd.

MPPHSCL | Bhopal, Madhya Pradesh

Amount: Refer DocsCloses: 16 Sept 2026

Timeline

Published21 Aug 2026
Pre-Bid Meeting24 Aug 2026
Submission Opens2 Sept 2026
Closes16 Sept 2026
Bid Opening17 Sept 2026

Tender Value

Refer Docs

EMD Value

₹2 L

Closing Date

16 Sept 2026, 3:00 pm

Tender Inviting Organisation

Name

Managing Director

Address

MPPHSCL, Bhopal

Work Description

Online Tender for the Rate Contract and Supply of Pharmaceuticals to Various Hospitals of Government of Madhya Pradesh for a Period of 18 months

Tender Information

Tender ID

2026_PHSCL_531333_1

Reference Number

T-947/MPPHSCL/Pharma/RC/2026, Date-21-08-2026

Tender Type

Open Tender

Product Category

Medicines

Form of Contract

Item Wise

Period of Work

45 days

Location

MPPHSCL

Source Website

Subscribe to view

Eligibility / Pre-Qualification

Please refer Tender documents.

Documents Required

23 documents required · 23 mandatory

Fee/PreQual/Technical

RequiredEMD Scan Copy (.pdf)

RequiredDocumentary evidence for the constitution of the company (.pdf)

RequiredThe instruments such as power of attorney (.pdf)

RequiredAuthorization letter nominating a responsible person (.pdf)

RequiredAnnual turnover statement for 3 years (.pdf)

RequiredGST registration certificate (Clearly showing GST no). (.pdf)

RequiredChecklist (Annexure XIV) (.pdf)

RequiredGS1 registration certificate (.pdf)

RequiredMandate Form (Annexure-XIII) (.pdf)

RequiredList of items and their quantity quoted (.pdf)

RequiredDeclaration in the format given in Annexure-II (.pdf)

RequiredValid own manufacturing license or valid import license issued by competent authority (.pdf)

RequiredAttested photocopy of import license (.pdf)

RequiredMarket standing cum performance Certificate (.pdf)

Requiredvalid WHO-GMP model certificate or valid USFDA/MHRA certificate (.pdf)

Requiredproduct wise Certificate of COPP/WHO-GMP or valid USFDA/MHRA certificate (.pdf)

RequiredBidder should be produce formulation wise annual production capacity certificate as per annexureVIII (.pdf)

RequiredClarification documents (.pdf)

RequiredThe bidder shall also furnish declaration in the format given in Annexure XVI (.pdf)

RequiredBidder must submit Merged Single PDF of all the above technical documents (.pdf)

RequiredBidder must submit Check list II (Annexure XVIII), in excel format. (.xls)

RequiredOther Documents if any. (.pdf)

Finance

RequiredPrice Sheet (.xls)

Fee & Financial Details

Tender Fee Amount

₹6,490

Tender Fee Exemption Allowed

Yes

EMD Fee Amount

₹2 L

EMD Fee Exemption Allowed

Yes

Pre-Bid Meeting

Meeting Place

MPPHSCL, Bhopal

Important Dates

Last Activity

21 Aug 2026

Published

21 Aug 2026

Bid Opening

17 Sept 2026

Download Starts

21 Aug 2026

Download Ends

16 Sept 2026

Submission Starts

2 Sept 2026

Pre-Bid Meeting

24 Aug 2026

Bill of Quantities

Item WiseBoQ_Ver4.0INR

BoQ1 (6 items)

Sl No	Description	Qty	Unit	Est. Rate	Est. Amount
1Drugs
1.01	Meropenem 1gm and Sulbactum 1gm Inj	240	vial	-	-
1.02	Cefepime 1gm and Tazobactam 1gm Inj	390	vial	-	-
1.03	Glutathione for Injection 1200mg	173	vial	-	-
1.04	Tecoplanin 600mg Injection	300	vial	-	-
1.05	Doripenem 1gm Injection	233	vial	-	-
1.06	Doripenem 500mg+ Sulbactum 500mg Injection	330	vial	-	-

Documents

Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.

Tender Page Snapshot

details.html

html • 0.04 MB

NIT Documents

Tendernotice_1.pdf

PDF • 0.95 MB

Work Item Documents

TenderDocumentT947.pdf

Tender Documents • 4.70 MB

SupplierFirmBiddingFormChecklistIIAnnexureXVIIIT947.xlsx

Ready to Participate?

Download all tender documents and submit your bid

Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].